Effectiveness of immunoglobulin replacement therapy in preventing infections in patients with chronic obstructive pulmonary disease: a systematic review.
Justin J Y KimLiz DennettMaria B OspinaAnne HicksHarissios VliagoftisAdil AdatiaPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2024)
It is unclear whether immune globulin replacement therapy reduces acute exacerbation frequency and severity in COPD. Current evidence suggests that it is worth considering, but better developed protocols for administration of immune globulin supplementation is required for future randomized controlled trials.
Keyphrases
- replacement therapy
- chronic obstructive pulmonary disease
- randomized controlled trial
- smoking cessation
- respiratory failure
- liver failure
- systematic review
- lung function
- drug induced
- current status
- clinical trial
- intensive care unit
- hepatitis b virus
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- cystic fibrosis